Coronavirus drug remdesivir to cost $3,120 per patient with private insurance
(NEW YORK) -- California-based drugmaker Gilead Sciences announced its pricing plans for remdesivir, an antiviral COVID-19 drug candidate, saying the treatment will cost $520 per dose for U.S. private insurance companies and $390 per dose......